Schrodinger, Inc. (SDGR)
NASDAQ:SDGR
Want to see SDGR full AI Analyst Report?
SDGR Stock Chart & Stats
$11.52
-$1.19(-5.63%)
At close: 4:00 PM EST
$11.52
-$1.19(-5.63%)
Day’s Range― - ―
52-Week Range$10.95 - $27.63
Previous CloseN/A
Volume166.74K
Average Volume (3M)1.18M
Market Cap
$980.40M
Enterprise Value$838.99M
Total Cash (Recent Filing)$395.46M
Total Debt (Recent Filing)$109.23M
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Aug 05, 2026EPS Estimate
-0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.42
Shares Outstanding64,660,910
10 Day Avg. Volume1,592,908
30 Day Avg. Volume1,181,440
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)3.61
Price to Sales (P/S)5.13
P/FCF Ratio105.42
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue3.28
Enterprise Value/Gross Profit5.88
Enterprise Value/Ebitda-9.79
Forecast
1Y Price Target
$19.25Price Target Upside67.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-2.12
Revenue Forecast (FY)$250.68M
Bulls Say, Bears Say
Bulls Say
AI Collaboration And Product DifferentiationExpanded collaboration with a major AI partner and the introduction of predictive toxicology capabilities could strengthen molecule‑design offerings and create differentiated growth opportunities.
Cost Discipline And Path To ProfitabilityCost reduction initiatives together with ample cash reserves support the plan to reach adjusted profitability while continuing to fund software growth initiatives.
Partnered Drug Discovery MomentumGrowth in partnered drug discovery revenues and the platform's ability to target oral therapeutics increase potential for milestone payments and royalty income as partner programs advance.
Bears Say
Acceleration Of Hosted License Transition RiskAn accelerated move to hosted licenses can create a reported software revenue shortfall before revenue recognition reaccelerates, increasing the risk of revenue misses under current reporting.
Analyst Valuation ConcernAn analyst lowering the price objective after updating estimates signals potential downside in market valuation if execution and visibility into the new business model do not improve.
Reported Revenue Recognition ImpactShifting from on‑premises to hosted software licenses defers revenue recognition and reduces reported software revenue, pressuring headline financial results.
Schrodinger News
SDGR FAQ
What was Schrodinger, Inc.’s price range in the past 12 months?
Schrodinger, Inc. lowest stock price was $10.95 and its highest was $27.63 in the past 12 months.
What is Schrodinger, Inc.’s market cap?
Schrodinger, Inc.’s market cap is $980.40M.
When is Schrodinger, Inc.’s upcoming earnings report date?
Schrodinger, Inc.’s upcoming earnings report date is Aug 05, 2026 which is in 89 days.
How were Schrodinger, Inc.’s earnings last quarter?
Schrodinger, Inc. released its earnings results on May 05, 2026. The company reported -$0.81 earnings per share for the quarter, missing the consensus estimate of -$0.623 by -$0.187.
Is Schrodinger, Inc. overvalued?
According to Wall Street analysts Schrodinger, Inc.’s price is currently Undervalued.
Does Schrodinger, Inc. pay dividends?
Schrodinger, Inc. does not currently pay dividends.
What is Schrodinger, Inc.’s EPS estimate?
Schrodinger, Inc.’s EPS estimate is -0.48.
How many shares outstanding does Schrodinger, Inc. have?
Schrodinger, Inc. has 64,660,910 shares outstanding.
What happened to Schrodinger, Inc.’s price movement after its last earnings report?
Schrodinger, Inc. reported an EPS of -$0.81 in its last earnings report, missing expectations of -$0.623. Following the earnings report the stock price went up 0.855%.
Which hedge fund is a major shareholder of Schrodinger, Inc.?
Currently, no hedge funds are holding shares in SDGR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Schrodinger Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.25 (67.10% Upside)
$19.25 (67.10% Upside)
Blogger Sentiment
Bullish
SDGR Sentiment 70%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 358.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 3.8%
Last 30 Days ▲ 3.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.07%
12-Months-Change
Fundamentals
Return on Equity
-29.47%
Trailing 12-Months
Asset Growth
-11.79%
Trailing 12-Months
Company Description
Schrodinger, Inc.
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
SDGR Company Deck
SDGR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlights robust top-line momentum (ACV growth of 12%), a large year-over-year surge in drug discovery revenue (~124%), strong product and R&D validation (Ajax acquisition, multiple exits, clinical data), meaningful progress migrating customers to hosted licensing, and an upcoming AI-driven product (Bunsen) expected to increase throughput and long‑term monetization. Offsetting these positives are near-term revenue recognition headwinds from the hosted transition, notable margin compression (software gross margin down 11 points), a steep drop in contribution revenue after a grant completed, and an ongoing net loss ($60M Q1), though management is exercising expense discipline and maintains guidance with a solid cash position (~$406M). On balance, the strategic wins, product momentum, and financial visibility (ACV guidance) materially outweigh the near-term recognition and margin challenges.View all SDGR earnings summariesSDGR Stock 12 Month Forecast
Average Price Target
$19.25
▲(67.10% Upside)
Technical Analysis
Ownership Overview
3.36% Insiders
20.44% Mutual Funds
10.24% Other Institutional Investors
41.17% Public Companies and
Individual Investors